It would seem to me that the oft repeated (in various investor presentations) 1H 2018 timeline for the reporting of results is well and truly not achievable.
Announced 31-08-2017: First patient dosing.
Announced 07-02-2017: Promising early results for first cohort and go ahead for increased dosing of next cohort.
That took over five months.
No further news in the three and a half months since. No announcement of proceeding to the third cohort. No announcement of any delay, but with only six weeks to go before the end of 1H 2018 and the trial nowhere near complete, there has surely been some sort of delay.
Vienna meeting?
IMU Price at posting:
3.8¢ Sentiment: Hold Disclosure: Held
